Speaker illustration

Doctor Carlos Santos-Gallego

Mount Sinai School of Medicine, New York (United States of America)

Pharmacological interventions: SGLT2 inhibitors in diabetic heart failure.

Event: ESC Congress 2021 - The Digital Experience

Topic: Risk Factors and Prevention

Session: Meet the Experts: fuel up! – targeting cardiac energy metabolism in type 2 diabetes and heart failure…


Gut microbiota and its dependent metabolite Trimethylamine N-oxide (TMAO) exacerbate adverse post-infarction left ventricular remodeling.

Event: ESC Congress 2017

Topic: Pathophysiology and diagnosis

Session: Chronic heart failure (CHF)


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb